Carbometrics announces new research collaboration with PyroScience We are excited to announce a research collaboration and option to license agreement with PyroScience GmbH, a world leader in optical sensor development. Our partnership aims to develop novel continuous glucose monitoring (CGM) sensors for use in bioprocessing and cell culture applications. This new opportunity perfectly complements our own efforts to develop the technology for CGM applications in the diabetes and intensive [...]

Carbometrics Ltd is pleased to announce that our Chairman of the Scientific Advisory Board, Professor Anthony Davis M.A. D.Phil. (Oxon.) FRSC has been awarded a prestigious ERC Advanced Grant totalling almost €2.5 million for his pioneering work on Glucose Binding Molecules. The awards, funded through the EU and worth up to €2.5 million each, allow established top researchers from across disciplines to explore their most creative ideas. The grants [...]

Senior Scientist Job Opportunity The successful candidate will work as part of the scientific team to support the research and development of Carbometrics technology. We are looking for someone to join the team who has some experience of working in a synthetic or analytical chemistry/biology laboratory. To thrive in this role, the successful candidate will have specific, hands-on, experience in the field of bioconjugations or other work applicable to [...]

Source: Beauhurst Carbometrics featured in Top 10 Bristol Tech Companies. Carbometrics is thrilled to be included in Beauhurst's list of ‘Top 10 Bristol Tech Companies’ for 2022, after a particularly successful year of fundraising totalling £4.14m. According to Beauhurst's report, tech companies based in Bristol make up 36% of the city's high-growth businesses. Over 208 startups and scaleups in this sector have a collective turnover of £4.69 billion and [...]

Appointment of Professor Anthony Davis M.A. D.Phil. (Oxon.) FRSC to Chairman of Advisory Board. Carbometrics Ltd is pleased to announce that Professor Anthony Davis M.A. D.Phil. (Oxon.) FRSC has accepted the invitation of the Carbometrics Board to become the first Chairman of Carbometrics Scientific Advisory Board (SAB). In his role as Chairman of Carbometrics SAB, Professor Davis will be supported by Dr Andy Chapman CEO of Carbometrics and by [...]

Glucose Binding Molecules that could revolutionize diabetes management. Carbometrics is one of the latest companies to feature in the web series ‘Science in Action' by Horiba scientific, which showcases cutting edge and innovative companies using their state-of-the-art analysis equipment. Head of Research Dr Rob Tromas and Research Operations Manager Stacy Coomber discuss the story behind the company, the science and the huge potential of the team's glucose receptor. “Scientists [...]

Science Creates Ventures Announces Second Investment From Its EIS Fund 1. Science Creates Ventures has made the second investment from its EIS fund 1 into Carbometrics, leading a £2.1m round with a syndicate of investors. Carbometrics, the spin-out of Ziylo, is developing a supramolecular Glucose Binding Molecule platform, working towards reliable, accurate and long-lasting glucose sensors. Andy Chapman, CEO of Carbometrics says: “This investment provides the runway that the company needs to [...]

Photo credit: TTP   Sensing with biomimetic glucose binding molecules. Carbometrics and TTP have combined their proficiencies to develop a range of glucose sensing solutions;  Carbometrics in the design and synthesis of highly selective and robust binding molecules and TTP’s expertise in electrochemistry, sensor transduction technologies. Carbometrics worked with TTP to understand how their unique ability to design, synthesise and derive highly selective and robust small molecule [...]

Carbometrics CEO Receives Royal Society of Chemistry’s Prestigious Rising Star in Industry Award.   Dr Andrew Chapman is the CEO and Co-founder at Carbometrics, a company that was spun out from Ziylo Ltd, where he was previously CSO prior to it’s sale to Novo Nordisk in 2018. The Royal Society of Chemistry recognised Andy for “leading the scientific team of a small diabetes spin-out company towards one of the [...]